Wentao Huang

Person

Shanghai, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds, compositions and methods
- Patent number 12,291,537
- Issue date May 6, 2025
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors targeting GPRC5D
- Patent number 12,281,162
- Issue date Apr 22, 2025
- LANOVA MEDICINES DEVELOPMENT CO., LTD.
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CEACAM5-dependent 4-1BB-agonistic bispecific antibodies
- Patent number 12,247,081
- Issue date Mar 11, 2025
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SLC34A2 monoclonal antibodies and uses thereof
- Patent number 12,215,150
- Issue date Feb 4, 2025
- LANOVA MEDICINES DEVELOPMENT CO., LTD.
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies targeting LIV-1 and uses thereof
- Patent number 12,194,106
- Issue date Jan 14, 2025
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies and antibody-drug conjugates targeting claudin 6
- Patent number 12,180,276
- Issue date Dec 31, 2024
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CCR8 monoclonal antibodies and uses thereof
- Patent number 11,873,342
- Issue date Jan 16, 2024
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-GPRC5D monoclonal antibodies and uses thereof
- Patent number 11,485,783
- Issue date Nov 1, 2022
- LANOVA MEDICINES DEVELOPMENT CO., LTD.
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CEACAM5-DEPENDENT 4-1BB-AGONISTIC BISPECIFIC ANTIBODIES
- Publication number 20250206834
- Publication date Jun 26, 2025
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING LIV-1 AND USES THEREOF
- Publication number 20250186601
- Publication date Jun 12, 2025
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-IL-13RA2 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20250163164
- Publication date May 22, 2025
- LaNova Medicines Development Co., Ltd.
- Runsheng LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SLC34A2 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20250154248
- Publication date May 15, 2025
- LaNova Medicines Development Co., Ltd.
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 6
- Publication number 20250109200
- Publication date Apr 3, 2025
- LaNova Medicines Limited
- Runsheng LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES TARGETING PD1 AND VEGF
- Publication number 20250019442
- Publication date Jan 16, 2025
- LaNova Medicines Limited
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-AMHRII ANTIBODIES
- Publication number 20240400701
- Publication date Dec 5, 2024
- LaNova Medicines Development Co., Ltd.
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-4-1BB NANOBODIES
- Publication number 20240383993
- Publication date Nov 21, 2024
- LaNova Medicines Limited
- Runsheng LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING LIV-1 AND USES THEREOF
- Publication number 20240325555
- Publication date Oct 3, 2024
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 6
- Publication number 20240317851
- Publication date Sep 26, 2024
- LaNova Medicines Limited
- Runsheng LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SLC34A2 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20240301052
- Publication date Sep 12, 2024
- LaNova Medicines Development Co., Ltd.
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEACAM5-DEPENDENT 4-1BB-AGONISTIC BISPECIFIC ANTIBODIES
- Publication number 20240294656
- Publication date Sep 5, 2024
- LaNova Medicines Limited
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20240262841
- Publication date Aug 8, 2024
- LaNova Medicines Limited
- Runsheng LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCR8 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20240141052
- Publication date May 2, 2024
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING GPRC5D
- Publication number 20230203160
- Publication date Jun 29, 2023
- LaNova Medicines Development Co., Ltd.
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-GPRC5D MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220220203
- Publication date Jul 14, 2022
- LaNova Medicines Development Co., Ltd.
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCR8 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220195057
- Publication date Jun 23, 2022
- LaNova Medicines Limited
- Runsheng Li
- C07 - ORGANIC CHEMISTRY

Wentao Huang

Person

Patents Grantslast 30 patents

Compounds, compositions and methods

Chimeric antigen receptors targeting GPRC5D

CEACAM5-dependent 4-1BB-agonistic bispecific antibodies

Anti-SLC34A2 monoclonal antibodies and uses thereof

Antibodies targeting LIV-1 and uses thereof

Antibodies and antibody-drug conjugates targeting claudin 6

Anti-CCR8 monoclonal antibodies and uses thereof

Anti-GPRC5D monoclonal antibodies and uses thereof

Patents Applicationslast 30 patents

CEACAM5-DEPENDENT 4-1BB-AGONISTIC BISPECIFIC ANTIBODIES

ANTIBODIES TARGETING LIV-1 AND USES THEREOF

ANTI-IL-13RA2 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTI-SLC34A2 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 6

BISPECIFIC ANTIBODIES TARGETING PD1 AND VEGF

ANTI-AMHRII ANTIBODIES

ANTI-4-1BB NANOBODIES

ANTIBODIES TARGETING LIV-1 AND USES THEREOF

ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 6

ANTI-SLC34A2 MONOCLONAL ANTIBODIES AND USES THEREOF

CEACAM5-DEPENDENT 4-1BB-AGONISTIC BISPECIFIC ANTIBODIES

COMPOUNDS, COMPOSITIONS AND METHODS

ANTI-CCR8 MONOCLONAL ANTIBODIES AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS TARGETING GPRC5D

ANTI-GPRC5D MONOCLONAL ANTIBODIES AND USES THEREOF

ANTI-CCR8 MONOCLONAL ANTIBODIES AND USES THEREOF